Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects-Reference-Cited by-同舟云学术

Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects

Published:2003-01 Issue:1 Volume:17 Page:53-63
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Anton Peter A,Mitsuyasu Ronald T,Deeks Steven G,Scadden David T,Wagner Bridget,Huang Christine,Macken Catherine,Richman Douglas D,Christopherson Cindy,Borellini Flavia,Lazar Richard,Hege Kristen M

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference25 articles.

1. Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

2. Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine

3. A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

4. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS

5. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Virally Suppressed People Living with HIV Who Use Opioids Have Diminished Latency Reversal;Viruses;2023-02-01

2. Photoinduced Photosensitizer–Antibody Conjugates Kill HIV Env-Expressing Cells, Also Inactivating HIV;ACS Omega;2021-06-08

3. Persistent HIV-1 Viremia on Antiretroviral Therapy: Measurement and Mechanisms;Frontiers in Microbiology;2019-10-15

4. Impacts of HIV Cure Interventions on Viral Reservoirs in Tissues;Frontiers in Microbiology;2019-08-21

5. Laboratory surrogate markers of residual HIV replication among distinct groups of individuals under antiretroviral therapy;PLOS ONE;2019-06-17